Accessibility Menu
Talphera logo

Talphera

(NASDAQ) ACRX

Current PriceN/A
Market CapN/A
Since IPO (2011)-99%
5 Year-98%
1 Year+32%
1 Month+2%

Talphera Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$342.00K

Net Income (TTM)

$12.39M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ACRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Talphera

Industry

Pharmaceuticals

Employees

13

CEO

Vincent J. Angotti, MBA

Headquarters

Hayward, CA 94545, US

ACRX Financials

Key Financial Metrics (TTM)

Gross Margin

-88%

Operating Margin

-465%

Net Income Margin

-442%

Return on Equity

-1%

Return on Capital

-47%

Return on Assets

-40%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$15.25M

EBITDA

$15.25M

Operating Cash Flow

$12.68M

Capital Expenditure

$0.00

Free Cash Flow

$12.68M

Cash & ST Invst.

$8.86M

Total Debt

$0.00

Talphera Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$1.00K

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

19

N/A

Net Income

$4.44M

-32.3%

EBITDA

$4.44M

-18.3%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$21.29M

+91.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-40.30%

N/A

Return on Invested Capital

-47.32%

N/A

Free Cash Flow

$2.51M

+14.5%

Operating Cash Flow

$2.51M

+14.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EMHTFEmerald Health Therapeutics, Inc.
$0.04+55.17%
CNPOFRIV Capital Inc.
$0.08+0.00%
NLTXNeoleukin Therapeutics, Inc.
$3.49+1.45%
RWBYFRed White & Bloom Brands Inc.
$0.03+1.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
IBITiShares Bitcoin Trust
$39.82-0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91+0.01%

Questions About ACRX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.